Oncolytics Intangibles To Total Assets from 2010 to 2024

ONC Stock  CAD 1.59  0.05  3.25%   
Oncolytics Biotech Intangibles To Total Assets yearly trend continues to be very stable with very little volatility. Intangibles To Total Assets are likely to drop to 0.01. Intangibles To Total Assets is the ratio of a company's intangible assets (like goodwill and patents) to its total assets. View All Fundamentals
 
Intangibles To Total Assets  
First Reported
2010-12-31
Previous Quarter
0.0149
Current Value
0.0141
Quarterly Volatility
0.08892227
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Oncolytics Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncolytics main balance sheet or income statement drivers, such as Depreciation And Amortization of 864.6 K, Interest Expense of 637.6 K or Selling General Administrative of 16.5 M, as well as many exotic indicators such as Price To Sales Ratio of 68.55, Dividend Yield of 0.0 or PTB Ratio of 4.61. Oncolytics financial statements analysis is a perfect complement when working with Oncolytics Biotech Valuation or Volatility modules.
  
This module can also supplement various Oncolytics Biotech Technical models . Check out the analysis of Oncolytics Biotech Correlation against competitors.
To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Oncolytics Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncolytics Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncolytics Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncolytics Biotech Stock:
Check out the analysis of Oncolytics Biotech Correlation against competitors.
To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.
Note that the Oncolytics Biotech information on this page should be used as a complementary analysis to other Oncolytics Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Oncolytics Stock analysis

When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Please note, there is a significant difference between Oncolytics Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncolytics Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncolytics Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.